Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1981 Nov;44(11):1020–1023. doi: 10.1136/jnnp.44.11.1020

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.

A J Lees, G M Stern
PMCID: PMC491206  PMID: 7334388

Abstract

The progress of 50 previously untreated patients with idiopathic Parkinson's disease taking maximum tolerated doses of bromocriptine is compared with patients who had taken levodopa. Twenty-eight of the bromocriptine treated patients showed sustained benefit for at least one year and in five this persisted longer than five years. Fewer of the late complications of levodopa therapy occurred in those taking bromocriptine; drug-induced dyskinesia was seen in only one patient and oscillations in performance were not observed. There was a tendency for deterioration to develop after two years treatment when patients then failed to respond well to levodopa. It was not possible to extend the period of effective control of disabilities by first giving bromocriptine.

Full text

PDF
1020

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CANTER G. J., DE LA TORRE R., MIER M. A method for evaluating disability in patients with Parkinson's disease. J Nerv Ment Dis. 1961 Aug;133:143–147. doi: 10.1097/00005053-196108000-00010. [DOI] [PubMed] [Google Scholar]
  2. Calne D. B., Plotkin C., Williams A. C., Nutt J. G., Neophytides A., Teychenne P. F. Long-term treatment of parkinsonism with bromocriptine. Lancet. 1978 Apr 8;1(8067):735–738. doi: 10.1016/s0140-6736(78)90856-5. [DOI] [PubMed] [Google Scholar]
  3. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  4. Lees A. J., Haddad S., Shaw K. M., Kohout L. J., Stern G. M. Bromocriptine in parkinsonism. A long-term study. Arch Neurol. 1978 Aug;35(8):503–505. doi: 10.1001/archneur.1978.00500320023005. [DOI] [PubMed] [Google Scholar]
  5. Quinn N., Illas A., Lhermitte F., Agid Y. Bromocriptine and domperidone in the treatment of Parkinson disease. Neurology. 1981 Jun;31(6):662–667. doi: 10.1212/wnl.31.6.662. [DOI] [PubMed] [Google Scholar]
  6. Stern G., Lees A. Bromocriptine in Parkinson's disease. Br J Hosp Med. 1978 Dec;20(6):666–670. [PubMed] [Google Scholar]
  7. Webster D. D. Critical analysis of the disability in Parkinson's disease. Mod Treat. 1968 Mar;5(2):257–282. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES